World

Moderna CEO: it’s all or nothing

[ad_1] The CEO of vaccine developer Covid-19 Moderna Inc. (NASDAQ: MRNA) might be getting a little ahead of himself. In an Endpoints interview the day before the company’s research and development day, Stéphane Bancel suggested that Cambridge, Massachusetts-based biotech could in the not-too-distant future have a research program that rivals …

Read More »